Category Archives: Cardiac Regeneration

Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. This type of medicine involves replacing and regenerating human cells, organs, and tissues with the help of specific processes Continue reading →

The rising geriatric population and the increasing prevalence of nerve injuries are driving the demand of the market. Continue reading →

PHOENIX, Dec. 10, 2020 /PRNewswire/ --Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company's ImmCelz product at generating what is termed in the field of immunology as "infectious tolerance." Using an animal model of rheumatoid arthritis, investigators demonstrated administration of ImmCel protected mice from immunologically mediated joint damage. Continue reading →

December 11, 2020 07:00 ET | Source: SANUWAVE Health, Inc. Highlights Significant Growth in Wound Care Franchise at Premier Small Cap Investor Conference Fourth Quarter 2020 Product Revenue to Grow 50% Sequentially; Fiscal 2021 Revenue to Increase More Than 300% SUWANEE, GA, Dec Continue reading →

Written by Anuradha Mascarenhas , Edited by Explained Desk | Pune | Updated: December 1, 2020 1:10:43 pm The ability of zebrafish to heal their heart after injury makes them an attractive model to investigate mechanisms governing the regenerative process. Zebrafish a tiny freshwater fish barely 2-3 cm long can efficiently regenerate its damaged heart within a short time period. Found in South Asia, it is a popular aquarium fish, frequently sold under the trade name Danio. Continue reading →

Zimmer Biomet Key Market Trends: Cardiology is Expected to hold its Highest Market Share in the Application Segment In the application segment of the market, cardiology is believed to have the largest market size and is expected to witness a CAGR of 16.0% during the forecast period. Recent years have observed promising applications of polymeric biomaterials in cardiac repair and regeneration. Organ failure is also one among the major health problems, globally recognized Continue reading →

Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. Continue reading →

Dr David A. Sinclair, Co-Director, Paul F. Glenn Center for Biology of Aging research, Harvard Medical School, in conversation with Sanchita Sharma, Editor - Health and Science, Hindustan Times, during the 18th edition of Hindustan Times Leadership Summit (HTLS), in New Delhi, India, on December 4, 2020.(HT photo) There is no reason to accept ageing as inevitable, Harvard professor Dr David Sinclair said on Friday, adding that if a pill or a vaccine is not developed in the next 30 years to fight ageing, something must have gone terribly wrong Continue reading →

iCrowdNewswire Dec 3, 20207:01 PM ET Plasma Therapy Marketsize is estimated to reach $470.04m by 2025, growing at a CAGR of 13.32% during the forecast period 2020-2025. Plasma is the yellowish liquid present in the blood, which carries the salts, enzymes and water. Plasma therapy is the method of treatment that is used for the healing of wounds, cardiac muscle injuries and others. Continue reading →

Research may lead to identifying novel therapies for cardiac patients (New York, NY November 19, 2020) Human placental stem cells may have the potential to regenerate heart tissue after a heart attack, according to Mount Sinai researchers who have received a $2.9 million grant from the National Institutes of Health to study them. Continue reading →